Expression of HIV-1 Vif and Human APOBEC3G with a Bicistronic Vector

Article Preview

Abstract:

Novel targets against HIV-1 are booming recently. APOBEC3G has the potential to inhibit the replication of HIV-1, while its antiviral activity is counteracted by Vif. The antiviral mechanism of APOBEC3G and the antagonistic mechanism of Vif have drawn great attention. Considering the occurrence of interaction between Vif and APOBEC3G should be based on that these two proteins coexist in the same cells, a eukaryotic bicistronic vector was adopted to express both Vif and APOBEC3G simultaneously. The expression and distribution of Vif and APOBEC3G proteins are detected with fluorescent microscope.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

141-145

Citation:

Online since:

October 2011

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2012 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] A. M. Sheehy, N. C. Gaddis, J. D. Choi, M. H. Malim, Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein, Nature, vol. 418, Aug. 2002, pp.646-650, doi: 10. 1038/nature00939.

DOI: 10.1038/nature00939

Google Scholar

[2] R. Suspene, P. Sommer, M. Henry, S. Ferris, D. Guetard, S. Pochet, et al, APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase, Nucleic Acids Res, vol. 32, Mar. 2004, pp.2421-2429.

DOI: 10.1093/nar/gkh554

Google Scholar

[3] H. Zhang, B. Yang, R. J. Pomerantz, C. Zhang, S. C. Arunachalam, L. Gao, The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA, Nature, vol. 424, Jul. 2003, pp.94-98, doi: 10. 1038/nature01707.

DOI: 10.1038/nature01707

Google Scholar

[4] K. Shindo, A. Takaori-Kondo, M. Kobayashi, A. Abudu, K. Fukunaga, T. Uchiyama, The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity, J. Biol. Chem, vol. 278, Nov. 2003, pp.44412-44416.

DOI: 10.1074/jbc.c300376200

Google Scholar

[5] R. Mariani, D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, et al, Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif, Cell, vol. 114, Jul. 2003, pp.21-31, doi: 10. 1016/S0092-8674(03)00515-4.

DOI: 10.1016/s0092-8674(03)00515-4

Google Scholar

[6] S. G. Conticello, R. S. Harris, M. S. Neuberger, The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G, Curr. Biol, vol. 13, Nov. 2003, pp.2009-2013, doi: 10. 1016/j. cub. 2003. 10. 034.

DOI: 10.1016/j.cub.2003.10.034

Google Scholar

[7] R. S. Harris, K. N. Bishop, A. M. Sheehy, H. M. Craig, S. K. Petersen-Mahrt, I. N. Watt, DNA deamination mediates innate immunity to retroviral infection, Cell, vol. 113, Jun. 2003, pp.803-809, doi: 10. 1016/S0092-8674(03)00423-9.

DOI: 10.1016/s0092-8674(03)00423-9

Google Scholar

[8] D. Lecossier, F. Bouchonnet, F. Clavel, A. J. Hance, Hypermutation of HIV-1 DNA in the absence of the Vif protein, Science, vol. 300, May. 2003, p.1112, doi: 10. 1126/science. 1083338.

DOI: 10.1126/science.1083338

Google Scholar

[9] B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, D. Trono, Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts, Nature, vol. 424, Jul. 2003, pp.99-103, doi: 10. 1038/nature01709.

DOI: 10.1038/nature01709

Google Scholar

[10] S. Kao, M. A. Khan, E. Miyagi, R. Plishka, A. Buckler-White, K. Strebel, The human immunodeficiency virus Type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity, J. Virol, vol. 77, Nov. 2003, pp.11398-11407, doi: 10. 1128/JVI. 77. 21. 11398-11407. (2003).

DOI: 10.1128/jvi.77.21.11398-11407.2003

Google Scholar

[11] A. Mehle, B. Strack, P. Ancuta, C. Zhang, M. McPike, D. Gabuzda, Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin–proteasome pathway, J. Biol. Chem, vol. 279, Feb. 2004, pp.7792-7798.

DOI: 10.1074/jbc.m313093200

Google Scholar

[12] X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, et al, Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif–Cul5–SCF complex, Science, vol. 302, Nov. 2003, pp.1056-1060, doi: 10. 1126/science. 1089591.

DOI: 10.1126/science.1089591

Google Scholar

[13] K. Stopak, C. de Noronha, W. Yonemoto, W. C. Greene, HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability, Mol. Cell, vol. 12, Sep. 2003, pp.591-601.

DOI: 10.1016/s1097-2765(03)00353-8

Google Scholar